Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296520301> ?p ?o ?g. }
- W4296520301 endingPage "118" @default.
- W4296520301 startingPage "101" @default.
- W4296520301 abstract "Biorelevant in vitro release models are valuable analytical tools for oral drug development but often tailored to gastrointestinal conditions in 'average' healthy adults. However, predicting in vivo performance in individual patients whose gastrointestinal conditions do not match those of healthy adults would be of great value for optimizing oral drug therapy for such patients. This study focused on establishing patient-specific in vitro and in silico models to predict the in vivo performance of levodopa extended-release products in Parkinson's disease patients. Current knowledge on gastrointestinal conditions in these patients was incorporated into model development. Relevant in vivo pharmacokinetic data and patient-specific in vitro release data from a novel in vitro test setup were integrated into patient-specific physiologically-based pharmacokinetic models. AUC, cmax and tmax of the computed plasma profiles were calculated using PK-Sim®. For the products studied, levodopa plasma concentration-time profiles modeled using this novel approach compared far better with published average plasma profiles in Parkinson's disease patients than those derived from in vitro release data obtained from the 'average' healthy adult setup. Although further work is needed, results of this study highlight the importance of addressing patient-specific gastrointestinal conditions when aiming to predict drug release in such specific patient groups." @default.
- W4296520301 created "2022-09-21" @default.
- W4296520301 creator A5037037002 @default.
- W4296520301 creator A5076600901 @default.
- W4296520301 date "2022-11-01" @default.
- W4296520301 modified "2023-10-01" @default.
- W4296520301 title "Patient-specific in vitro drug release testing coupled with in silico PBPK modeling to forecast the in vivo performance of oral extended-release levodopa formulations in Parkinson’s disease patients" @default.
- W4296520301 cites W1486185235 @default.
- W4296520301 cites W1499768710 @default.
- W4296520301 cites W1517020700 @default.
- W4296520301 cites W1522767714 @default.
- W4296520301 cites W1964575627 @default.
- W4296520301 cites W1971114420 @default.
- W4296520301 cites W1976884564 @default.
- W4296520301 cites W1976931129 @default.
- W4296520301 cites W1979475426 @default.
- W4296520301 cites W1980384054 @default.
- W4296520301 cites W1981461721 @default.
- W4296520301 cites W1983005791 @default.
- W4296520301 cites W1988808239 @default.
- W4296520301 cites W1988824288 @default.
- W4296520301 cites W1989738331 @default.
- W4296520301 cites W1991201604 @default.
- W4296520301 cites W1995091230 @default.
- W4296520301 cites W1996813582 @default.
- W4296520301 cites W1999319737 @default.
- W4296520301 cites W2000029251 @default.
- W4296520301 cites W2006931745 @default.
- W4296520301 cites W2013015976 @default.
- W4296520301 cites W2014583561 @default.
- W4296520301 cites W2017692438 @default.
- W4296520301 cites W2021117200 @default.
- W4296520301 cites W2024634604 @default.
- W4296520301 cites W2025247403 @default.
- W4296520301 cites W2025961817 @default.
- W4296520301 cites W2028165836 @default.
- W4296520301 cites W2029933753 @default.
- W4296520301 cites W2034613829 @default.
- W4296520301 cites W2041981746 @default.
- W4296520301 cites W2054399253 @default.
- W4296520301 cites W2057495253 @default.
- W4296520301 cites W2064419430 @default.
- W4296520301 cites W2064996887 @default.
- W4296520301 cites W2070914201 @default.
- W4296520301 cites W2071138535 @default.
- W4296520301 cites W2073953969 @default.
- W4296520301 cites W2077226523 @default.
- W4296520301 cites W2078117301 @default.
- W4296520301 cites W2079610146 @default.
- W4296520301 cites W2085444179 @default.
- W4296520301 cites W2088812362 @default.
- W4296520301 cites W2089039929 @default.
- W4296520301 cites W2092627924 @default.
- W4296520301 cites W2092772514 @default.
- W4296520301 cites W2093740203 @default.
- W4296520301 cites W2093925516 @default.
- W4296520301 cites W2095179999 @default.
- W4296520301 cites W2095889210 @default.
- W4296520301 cites W2100984307 @default.
- W4296520301 cites W2113830209 @default.
- W4296520301 cites W2115848859 @default.
- W4296520301 cites W2125930252 @default.
- W4296520301 cites W2126241900 @default.
- W4296520301 cites W2133756607 @default.
- W4296520301 cites W2134340482 @default.
- W4296520301 cites W2136427073 @default.
- W4296520301 cites W2137752893 @default.
- W4296520301 cites W2160934926 @default.
- W4296520301 cites W2161960967 @default.
- W4296520301 cites W2165334931 @default.
- W4296520301 cites W2167720771 @default.
- W4296520301 cites W2222899743 @default.
- W4296520301 cites W2324964702 @default.
- W4296520301 cites W2325533081 @default.
- W4296520301 cites W2337916718 @default.
- W4296520301 cites W2339836752 @default.
- W4296520301 cites W2468463812 @default.
- W4296520301 cites W2522795135 @default.
- W4296520301 cites W2567300897 @default.
- W4296520301 cites W2587129789 @default.
- W4296520301 cites W2589517828 @default.
- W4296520301 cites W2748434315 @default.
- W4296520301 cites W2759142878 @default.
- W4296520301 cites W2769601732 @default.
- W4296520301 cites W2806979378 @default.
- W4296520301 cites W2906381701 @default.
- W4296520301 cites W2914824799 @default.
- W4296520301 cites W2966464751 @default.
- W4296520301 cites W3008414764 @default.
- W4296520301 cites W3027974929 @default.
- W4296520301 cites W30775475 @default.
- W4296520301 cites W4200433813 @default.
- W4296520301 cites W2061627025 @default.
- W4296520301 doi "https://doi.org/10.1016/j.ejpb.2022.09.015" @default.
- W4296520301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36150616" @default.
- W4296520301 hasPublicationYear "2022" @default.
- W4296520301 type Work @default.
- W4296520301 citedByCount "2" @default.